Concepedia

Oluwatoyin Shonukan

OS

Statistics

Publications

8

Citations

833

H-Index

8

Active since

1998

Affiliations

Eli Lilly (United States)(Current)

Texas Oncology

Indiana University – Purdue University Indianapolis

University Hospital Cologne

Oluwatoyin Shonukan is an author at Eli Lilly (United States) specializing in medicine, oncology, and breast cancer.

Top concepts

Publications per year

1998–2016

8

Publications

8

Frequent Dysregulation of the c-maf Proto-Oncogene at 16q23 by Translocation to an Ig Locus in Multiple Myeloma

Marta Chesi, P. Leif Bergsagel, Oluwatoyin Shonukan et al. · Blood · 1998 · 373 citations

Frequent Dysregulation of the c-maf Proto-Oncogene at 16q23 by Translocation to an Ig Locus in Multiple Myeloma

Marta Chesi, P. Leif Bergsagel, Oluwatoyin Shonukan et al. · Blood · 1998 · 184 citations

Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group

Stefanie Kreissl, Horst Mueller, Helen Goergen et al. · The Lancet Oncology · 2016 · 113 citations

, , +3

Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration

Karolin Behringer, Helen Goergen, Horst Müller et al. · Journal of Clinical Oncology · 2016 · 93 citations

A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen

Lida A. Mina, Ian E. Krop, Robin Zoň et al. · Investigational New Drugs · 2009 · 30 citations

, , +9

1–5 of 8